These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 910412)

  • 1. Clinical studies on the ventricular bypass with local heparinization in 8 consecutive patients.
    Taguchi K; Mochizuki T; Takamura K; Murashita J; Maruyama T
    Trans Am Soc Artif Intern Organs; 1977; 23():739-40. PubMed ID: 910412
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular or biventricular bypass with local heparinization.
    Taguchi K; Murashita J; Maruyama T; Nakagaki M; Mochizuki T
    Trans Am Soc Artif Intern Organs; 1977; 23():498-505. PubMed ID: 910372
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of heparin therapy in open-heart surgery.
    Jaberi M; Bell WR; Benson DW
    J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
    [No Abstract]   [Full Text] [Related]  

  • 4. Transapical left ventricular bypass with local heparinization for prolonged circulatory support.
    Taguchi K; Murashita J; Nakagaki M; Mochizuki T
    World J Surg; 1980; 4(2):251-9. PubMed ID: 7405262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.
    Ranucci M; Cazzaniga A; Soro G; Isgrò G; Frigiola A; Menicanti L
    J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):316-20. PubMed ID: 12073203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Kleesiek K; Körfer R
    Artif Organs; 2001 Jun; 25(6):480-5. PubMed ID: 11453879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose heparin preoperatively for prophylaxis against postoperative thromboembolism.
    Brantigan OC
    Md State Med J; 1979 Feb; 28(2):61-4. PubMed ID: 423621
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic heparinization for angiography.
    Wallace S; Medellin H; De Jongh D; Gianturco C
    Am J Roentgenol Radium Ther Nucl Med; 1972 Sep; 116(1):204-9. PubMed ID: 5055641
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic heparinization for femoral percutaneous coronary arteriography.
    Walker WJ; Mundall SL; Broderick HG; Prasad B; Kim J; Ravi JM
    N Engl J Med; 1973 Apr; 288(16):826-8. PubMed ID: 4693933
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Subcutaneous heparin and postoperative thromboembolism.
    Brozović M; Stirling Y; Klenerman L; Lowe L
    Lancet; 1974 Jul; 2(7872):99-100. PubMed ID: 4137004
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of systemic arterial heparinization in transfemoral angiography: a prospective study.
    Antonovic R; Rösch J; Dotter CT
    AJR Am J Roentgenol; 1976 Aug; 127(2):223-5. PubMed ID: 181997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparin therapy and burns].
    Guimbretière J; Lebeaupin R; Pannier M
    Anesth Analg (Paris); 1977; 34(6):1339-44. PubMed ID: 613885
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuraxial anesthesia and timing of heparin administration in patients undergoing surgery for congenital heart disease using cardiopulmonary bypass.
    Weiner MM; Rosenblatt MA; Mittnacht AJ
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):581-4. PubMed ID: 22155166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of preoperative in vitro and in vivo studies for correct individual heparinization in cardiac surgery.
    Ponari O; Corsi M; Manotti C; Pini M; Portioli D; Poti R
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):87-94. PubMed ID: 449390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravenous heparin administration after endovascular treatment for ruptured intracranial aneurysms.
    Vance AZ; Jayaraman MV; Dubel GJ; Doberstein CE; Haas RA
    J Neurointerv Surg; 2009 Dec; 1(2):136-41. PubMed ID: 21994283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications.
    Kroese A; Dobloug I
    J Oslo City Hosp; 1976 Apr; 26(4):45-7. PubMed ID: 1263020
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing survival and successful weaning from clinical ventricular bypass with local heparinization and blood filtration: an analysis in 21 consecutive patients.
    Taguchi K; Murashita J; Nakagaki M; Mochizuki T; Matsumura M; Tsuchiya T
    Trans Am Soc Artif Intern Organs; 1979; 25():176-81. PubMed ID: 524578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose heparin therapy in the long-term management of venous thromboembolism.
    Bynum LJ; Wilson JE
    Am J Med; 1979 Oct; 67(4):553-6. PubMed ID: 386791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior hemodynamics in left heart bypass without systemic heparinization.
    von Segesser LK; Weiss BM; Gallino A; Leskosek B; Redha F; von Felten A; Turina M
    Eur J Cardiothorac Surg; 1990; 4(7):384-8; discussion 389. PubMed ID: 2397131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.